{name}
{subtitle}
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~5 mi. (Seneca, Pennsylvania, +469 more cities)
facility
UPMC Cancer Center at UPMC Northwest
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
city
~5 mi. (Seneca, Pennsylvania, +224 more cities)
facility
UPMC Cancer Center at UPMC Northwest
condition
Hypopharyngeal Carcinoma, +3 more conditions
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +3 more types
Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
city
~5 mi. (Seneca, Pennsylvania, +142 more cities)
facility
UPMC Cancer Center at UPMC Northwest
drug
apalutamide, +2 more drugs
drug type
hormone therapy, +1 more type
SWOG S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
city
~5 mi. (Seneca, Pennsylvania, +210 more cities)
facility
UPMC Cancer Center at UPMC Northwest
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
city
~36 mi. (Meadville, Pennsylvania, +638 more cities)
facility
Yolanda G Barco Oncology Institute
drug
bevacizumab, +3 more drugs
drug type
chemotherapy, +2 more types
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
city
~57 mi. (Orangeville, Ohio, +100 more cities)
facility
UH Minoff Health Center - Seidman
condition
Fallopian Tube Adenocarcinoma, +14 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~59 mi. (Kittanning, Pennsylvania, +825 more cities)
facility
Armstrong Center for Medicine and Health
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type